Service Overview
Evaluate drug-likeness, pharmacokinetics, and safety profile early.
What this service is
ADMET analysis predicts absorption, distribution, metabolism, excretion, and toxicity properties of candidate compounds. It is an essential step because a strong docking compound may still fail if it has poor pharmacokinetic behavior or high toxicity risk.
How it helps you
This service helps researchers prioritize compounds that are more likely to be safe, bioavailable, and suitable for further development. It is useful after docking or virtual screening to filter the strongest hits based on drug-likeness and safety.
What you receive from us
You receive ADMET and drug-likeness tables, interpretation of absorption and distribution, CYP/metabolism risk, excretion indicators, toxicity flags, and a clear lead-prioritization summary. Each project is delivered within a maximum of one week. You receive a complete publication-ready scientific report including Materials and Methods, Results, Discussion, References, clear tables, high-quality figures when applicable, and full follow-up until publication, including support with reviewer comments and journal responses.
Service advantages
- Early safety and pharmacokinetic filtering
- Drug-likeness and lead prioritization
- we perform analysis in max 1-week
- we follow up until publication , any reviews pr questions we can revise and replay
- Toxicity and CYP risk interpretation
- Publication-ready report within one week plus full journal follow-up
- you receive a complete report , material and method . result , discussion and references with publishable resolution figures